ScholarIQanswers from OpenAlex

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

PaperCitations, authors & open-access status

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma have?

ScholarIQcitation count

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma has 1,176 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma published?

ScholarIQyear

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma has 2018 year in the ScholarIQ index.

What is the open-access status of Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma?

ScholarIQoa status

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma has bronze oa status in the ScholarIQ index.

What is the DOI of Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma?

ScholarIQdoi

The DOI for Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma is on the source record.

What is the PMID of Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma?

ScholarIQpmid

The PMID for Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma is on the source record.

What is the OpenAlex record for Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma?

ScholarIQopenalex

The OpenAlex for Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial